Bronchodilator Properties and Safety of a Repeated Dose of V0162 in Asthma.
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2014
Price : $35 *
At a glance
- Drugs V 0162 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 19 Jul 2014 According to the European Clinical Trials Database record, status changed from recruiting to completed.
- 19 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Oct 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2013-002517-35).